Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report

Sofia Ventura1, Raquel Cabral1, Carolina Viveiros2

  • 1Nephrology, Hospital do Divino Espírito Santo, EPER, Ponta Delgada, PRT.

Cureus
|January 23, 2023
PubMed

Insights

Monoclonal gammopathy of renal significance (MGRS) can cause rapidly progressing kidney failure, often presenting as thrombotic microangiopathy (TMA). Early diagnosis and treatment are crucial, though outcomes can be poor even with standard therapies.

Area of Science:

  • Nephrology
  • Hematology
  • Pathology

Background:

  • Monoclonal gammopathy of renal significance (MGRS) encompasses kidney disorders linked to monoclonal proteins in patients without overt B-cell malignancies.
  • Diagnosing MGRS is complex due to numerous associated kidney diseases, with new associations continually being identified.
  • The connection between monoclonal gammopathies and thrombotic microangiopathy (TMA) is an emerging area of clinical interest.

Related Concept Videos